[HTML][HTML] Cross section measurement of terbium radioisotopes for an optimized 155Tb production with an 18 MeV medical PET cyclotron
G Dellepiane, P Casolaro, C Favaretto… - Applied radiation and …, 2022 - Elsevier
Abstract 155 Tb [t 1/2= 5.32 d, E γ= 87 keV (32%); 105 keV (25%)(IAEA, 2021) is a novel
promising radionuclide for theranostic applications in nuclear medicine. Its physical …
promising radionuclide for theranostic applications in nuclear medicine. Its physical …
[HTML][HTML] Alternative routes for 64Cu production using an 18 MeV medical cyclotron in view of theranostic applications
G Dellepiane, P Casolaro, I Mateu, P Scampoli… - Applied Radiation and …, 2023 - Elsevier
Radiometals play a fundamental role in the development of personalized nuclear medicine.
In particular, copper radioisotopes are attracting increasing interest since they offer a varying …
In particular, copper radioisotopes are attracting increasing interest since they offer a varying …
[HTML][HTML] Cross-section measurement for an optimized 61Cu production at an 18 MeV medical cyclotron from natural Zn and enriched 64Zn solid targets
G Dellepiane, P Casolaro, I Mateu, P Scampoli… - Applied Radiation and …, 2022 - Elsevier
The availability of novel medical radionuclides is a key point in the development of
personalised nuclear medicine. In particular, copper radioisotopes are attracting …
personalised nuclear medicine. In particular, copper radioisotopes are attracting …
[HTML][HTML] Optimized production of 67Cu based on cross section measurements of 67Cu and 64Cu using an 18 MeV medical cyclotron
G Dellepiane, P Casolaro, A Gottstein, I Mateu… - Applied Radiation and …, 2023 - Elsevier
RadioNuclide Therapy (RNT) in nuclear medicine is a cancer treatment based on the
administration of radioactive substances that specifically target cancer cells in the patient …
administration of radioactive substances that specifically target cancer cells in the patient …
New developments for theranostic radioisotope production with solid targets at the Bern medical cyclotron
G Dellepiane, P Casolaro, I Mateu… - Journal of Physics …, 2023 - iopscience.iop.org
The concept of theranostics in nuclear medicine is based on the use of a pair of
radioisotopes to label radiopharmaceuticals for both diagnosis and therapy and is essential …
radioisotopes to label radiopharmaceuticals for both diagnosis and therapy and is essential …
Novel solid target and irradiation methods for theranostic radioisotope production at the Bern medical cyclotron
G Dellepiane, P Casolaro, A Gottstein… - EPJ Web of …, 2023 - epj-conferences.org
The production of medical radioisotopes for theranostics is essential for the development of
personalized nuclear medicine. Among them, radiometals can be used to label proteins and …
personalized nuclear medicine. Among them, radiometals can be used to label proteins and …
[PDF][PDF] Accelerator and Detector Developments for the Production of Theranostic Radioisotopes with Solid Targets at the Bern Medical Cyclotron
A Gottstein, P Casolaro, G Dellepiane, I Mateu… - inspirehep.net
Theranostics in nuclear medicine is realized by using two different radionuclides to label the
same radiopharmaceutical, one for diagnosis via PET or SPECT (positron or gamma emitter …
same radiopharmaceutical, one for diagnosis via PET or SPECT (positron or gamma emitter …